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Plexiform Angiomyxoid Myofibroblastic Tumor of the Stomach: 
A Case Report 
Plexiform angiomyxoid myofibroblastic tumor (PAMT) is a recently described mesenchymal 
tumor of the stomach. We report the first case of PAMT in Korea. A 52-yr-old man 
underwent esophagogastroduodenoscopy due to dyspepsia for 2 yr. There was a 
submucosal mass with small mucosal ulceration in the gastric antrum. The tumor measured 
3.5 × 2.3 cm in size and showed multinodular plexiform growth pattern of bland-looking 
spindle cells separated by an abundant myxoid or fibromyxoid matrix rich in small thin-
walled blood vessels. The tumor cells were negative for CD117 (c-KIT), CD34 and S-100 
protein, but diffusely positive for smooth muscle actin consistent with predominant 
myofibroblastic differentiation. The patient is doing well without recurrence or metastasis 
for 5 months after surgery. Although there have been limited follow-up data, PAMT is 
regarded as a benign gastric neoplasm with histological and immunohistochemical 
charateristics distinguished from gastrointestinal stromal tumor and other mesenchymal 
tumors of the stomach.
Key Words: Plexiform Angiomyxoid Myofibroblastic Tumor; Stomach; Myofibroblast; 
Fibromyxoma; Plexiform
Aeri Kim, Young Kyung Bae,  
Hyeong Chan Shin and Joon Hyuk Choi 
Department of Pathology, Yeungnam University 
College of Medicine, Daegu, Korea
Received: 8 July 2011
Accepted: 21 September 2011
Address for Correspondence:
Young Kyung Bae, MD
Department of Pathology, College of Medicine, Yeungnam 
University, 170 Hyeonchung-ro, Nam-gu, Daegu 705-717, Korea
Tel: +82.53-620-3336, Fax: +82.53-622-8432
E-mail: ykbae@ynu.ac.kr
*This research was supported by the Yeungnam University 
research grants in 2009.




The most common gastrointestinal mesenchymal tumor is a 
gastrointestinal stromal tumor (GIST) (1). Plexiform angiomyx-
oid myofibroblastic tumor (PAMT) is a recently described mes-
enchymal tumor of the stomach, characterized by plexiform 
nodular growth of bland spindle cells in myxoid or fibromyxoid 
stroma (2). Although myxoid tumors of the stomach have been 
described as gastric myxoma and fibromyxoma in the older liter-
ature before the concept of PAMT (3), we could find 22 tumors 
similar to our case in the literature under the diagnostic name 
of PAMT, plexiform angiomyxoid tumor or plexiform fibromyx-
oma since Takahashi et al. (2) first described in 2007 (3-10). Here 
we would like to report a new case of PAMT of gastric antrum, 
including preoperative endoscopic biopsy findings and a review 
of the literature. To the best of our knowledge it must be the first 
PAMT case in Korea.
CASE DESCRIPTION 
A 52-yr-old man visited the hospital due to gastric mass found 
at local clinic on January 11, 2011. He has no specific symptom 
except dyspepsia for 2 yr. On esophagogastroduodenoscopic 
examination, about 5 cm-sized movable mass with mucosal ul-
ceration was detected in the gastric antrum (Fig. 1A). An endo-
scopic biopsy was done under the clinical impression of GIST. 
Pathologic examination of the mass showed an ill-defined myx-
oid lesion composed of loosely scattered bland spindle cells 
and small thin-walled blood vessels in the gastric mucosa (Fig. 
1B). The spindle cells were positive for smooth muscle actin 
(SMA) (1A4, 1:40, Dakocytomation, Carpinteria, CA, USA), but 
negative for CD117 (polyclonal, 1:250, Dakocytomation), CD34 
(QBEND10, 1:30, Dakocytomation) and S-100 protein (poly-
clonal, 1:150, Zymed, San Francisco, CA, USA) immunostains 
(Fig. 1C, D). Histological findings favored a benign mesenchy-
mal tumor, but no precise diagnosis was made. Endoscopic ul-
trasonogram revealed a 2.3 × 2.1 cm-sized hypoechoic lesion in 
muscle proper layer, but abdominal CT had no remarkable find-
ing. The patient underwent laparoscopic wedge resection of the 
gastric mass on February 28, 2011.
  A gross examination showed a multinodular glistening mass 
of  3.5 × 2.3 cm in size, with an umbilicated ulcer in the overlying 
mucosa (Fig. 2A). The mass was mainly located in the submu-
cosal layer and poorly demarcated from the muscularis propria 
(Fig. 2B). Microscopically, the tumor showed a multinodular 
plexform growth pattern dissecting the wall (Fig. 3A). The tumor 
nodules consisted of bland-looking spindle cells separated by 
an abundant myxoid or fibromyxoid matrix (Fig. 3B, C). Fascic-
ular or palisading arrangement of the tumor cells was also not-
ed (Fig. 3D). Numerous small thin-walled blood vessels were Kim A, et al.  •  Plexiform Angiomyxoid Myofibroblastic Tumor
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observed in the myxoid stroma (Fig. 3E). In some nodules, the 
collagenous stroma was densely hyalinized. The spindle tumor 
cells had no significant nuclear atypia and mitotic activity. Im-
munohistochemically, they were diffusely positive for SMA and 
focally positive for desmin (ZC18, 1:60, Zymed) (Fig. 3F), but 
negative for CD117, CD34 and S-100 protein as described in the 
endoscopic biopsy. The patient received supportive care with-
out any specific medication during hospitalization and had no 
Fig. 1. Endoscopic examination of the tumor. (A) The stomach shows a submucosal mass with small mucosal ulceration in the antrum. (B) The biopsied mucosa shows an ill-





Fig. 2. Gross examination of the excised specimen. (A) There is a protruding multinodular glistening mass, mainly located in the submucosa. (B) Cut surface showed myxoid 
nature and unclear margin of the tumor. Kim A, et al.  •  Plexiform Angiomyxoid Myofibroblastic Tumor
1510   http://jkms.org http://dx.doi.org/10.3346/jkms.2011.26.11.1508
recurrence or metastasis in the follow-up for 5 months after the 
surgery.
DISCUSSION
PAMT of the stomach is a very rare neoplasm. Miettinen et al. (3) 
estimated the incidence of PAMT as less than 1/150 compared 
with that of gastric GIST. It occurs over a wide range of ages (3, 
8). When we analyzed all 23 PAMTs including this case, based 
on the previous reports (2-10), age of the patients ranged from 
7 to 75 yr (mean, 42 yr) and there were 12 males and 11 females. 
All of the tumors occurred in the gastric antrum, therefore they 
could be excised by partial or distal gastrectomy. More than half 
of the cases (13/23) showed erosion or ulceration of gastric mu-
cosa, and gastrointestinal bleeding was the most common symp-
tom. The tumor size ranged from 1.9 to 15 cm (mean, 6.1 cm). 
Immunohistochemically, all cases were positive for muscle spe-
cific actin or SMA and negative for CD117 (KIT), CD34 and S-100 
protein. There was focal positivity for caldesmon, desmin, or 
CD10 in some cases (3, 8).
  Takahashi et al. (2) named two cases of tumor, which have not 
been described previously, as PAMT to designate a peculiar his-
tology (plexiform growth pattern, a myxoid stroma rich in small 
vessels) and cell nature (myofibroblastic origin). They confirmed 
myofibroblastic nature of tumor cells by immunohistochemical 
and ultrastructural analyses. PAMT is mainly composed of tu-
mor cells with myofibroblastic phenotype, but may also contain 
tumor cells with fibroblastic or smooth muscle characteristics. 
Miettinen et al. (3) reported the presence of tumor cells with fi-
broblastic traits (focal CD10-positivity) and Yoshida et al. (6) re-
ported that a minority of tumor cells possess smooth muscle dif-
ferentiation (focal positivity for desmin and caldesmon, blunted 
end nuclei and long eosinophilic cytoplasmic extensions). They 
proposed terms such as “plexiform fibromyxoma” and “plexi-
form angiomyxoid tumor” respectively to describe tumors sim-
ilar to PAMT. Our case showed a focal immunoreactivity for des-
min consistent with smooth muscle differentiation, in addition 
to diffuse positivity for SMA consistent with myofibroblastic dif-
ferentiation. Because the majority of cases have represented pre-
dominant myofibroblastic nature of tumor cells as in our case, 
we think that PAMT is an appropriate diagnostic term to cover 
histogenesis and histology. However, the WHO classification of 
tumors of the digestive system accepted “plexiform fibromyxo-
ma” as a diagnostic term instead of PAMT (1). Plexiform fibro-
myxoma, proposed by Miettinen et al. (3), was based on histo-
logical appearance of tumors and stromal spectrum from exten-
sively myxoid to collagenous. However, Sing et al. (9) suggested 
that plexiform fibromyxoma is distinguished from PAMT by im-
munohistochemical and clinicopathologic features. Mean tu-
mor size of plexiform fibromyxoma was larger than that of PAMT 
and vascular invasion and extragastric extension of the tumor 
were typically observed in plexiform fibromyxomas, but not in 
PAMT. In addition, desmin and caldesmon showed no reactivi-
ty in plexiform fibromyxoma, but they were focally positive in 
PAMT. Based on these findings they considered PAMT and plexi-
form fibromyxoma as related entities with variable fibroblastic-
Fig. 3. Microscopic examination of the tumor. (A) The tumor showed plexiform growth pattern dissecting the muscularis propria (H&E, × 10). The bland-looking spindle tumor 
cells were separated by abundant myxoid (B) or fibromyxoid stroma (C) (H&E, × 100). (D) Palisading arrangement of tumor cells was noted (H&E, × 200). (E) There were nu-
merous thin-walled vessels in the myxoid stroma (H&E, × 200). (F) The tumor cells were focally positive for desmin immunostain (× 200).
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myofibroblastic differentiation, with plexiform fibromyxoma 
occupying the dominant fibroblastic end of spectrum, while 
PAMT is fully differentiated myofibroblastic tumor.
  PAMT should be separated from other myxoid and fibromyx-
oid tumors of the stomach including myxoid variant of GIST, 
myxoid leiomyoma, plexiform neurofibroma and inflammatory 
fibroid polyp. GIST does not show the distinctive plexiform in-
tramural growth pattern and are typically positive for CD117 or 
DOG1. Myxoid leiomyoma is positive for SMA, desmin and calde-
smon and plexiform neurofibroma is positive for S-100 protein. 
Inflammatory fibroid polyp is usually small submucosal lesion 
composed of epithelioid to spindled fibroblasts and inflamma-
tory cells.
  Although the true biologic potential of PAMT remains un-
known due to its rarity and limited follow-up data, the short term 
prognosis has been good with no recurrence or metastasis re-
ported. Histological features such as bland nuclear morpholo-
gy, low proliferative index, no necrosis suggest that PAMT is a 
benign tumor. 
  Here we report the first case of PAMT in Korea. PAMT has a 
distinctive histological and immunohistochemical features dis-
tinguished from GIST and other mesenchymal tumors. When 
myxoid spindle cell lesion is observed in endoscopic biopsy, 
PAMT should be included in differential diagnosis. 
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